On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-26 October 2019 and includes updates on chikungunya, dengue, eastern equine encephalitis, Ebola virus, influenza, mass gathering monitoring in Japan.
This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.
This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia based on data provided by countries for reporting on the Dublin Declaration in 2018.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 8-14 September 2019 and includes updates on Ebola virus disease, dengue, chikungunya, Vibrio growth in the Baltic Sea, and West Nile virus.
In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.